Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by toinv261on May 28, 2014 12:44pm
236 Views
Post# 22605845

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Lack of communications

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Lack of communicationsHi GV.
 
Interesting. From my perspective I don't really care too much about insider control. And, if there are lot's of family and friends in there then Don better get performing.
 
What I do care about is action and we are not getting any other than the diabetes trial that is ongoing. They don't even have the decency to communicate with us. Does anyone have an inside contact or a friend that has an inside contact so we could get some information.
 
I'm really surprised that there are no rumours within the scientific or investment communities. Everything is silent and that makes me wonder. If they are negotiating then someone would get hints about it unless they are brilliant about keeping secrets.
 
Your point about KD got me thinking that perhaps KD has changed his mind regarding RVX and in fact he may not be in agreement with Don's direction, although, if I remember correctly Eastern and NGN did put money into Zenith. I'm just thinking that there may be a roadblock that relates to the RVX side of things. Given that KD also has to cover the line of credit he must be motivated to get some action. Perhaps we will see a new board and perhaps Don will be replaced. I'm sure Eastern wants a good ROI out it's investment.
 
I also wonder why Higgins resigned from the board. I recognize his role was to guide the spinco formation but he would be on the board if he saw there was something there for Blackrock(stone).
 
Anyway, just rambling. I remain in the dark but hopeful. It's been 11 months!!!
Cheers
Toinv
Bullboard Posts